BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24567196)

  • 1. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures.
    Drews-Elger K; Brinkman JA; Miller P; Shah SH; Harrell JC; da Silva TG; Ao Z; Schlater A; Azzam DJ; Diehl K; Thomas D; Slingerland JM; Perou CM; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2014 Apr; 144(3):503-17. PubMed ID: 24567196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24(+) cells fuel rapid tumor growth and display high metastatic capacity.
    Rostoker R; Abelson S; Genkin I; Ben-Shmuel S; Sachidanandam R; Scheinman EJ; Bitton-Worms K; Orr ZS; Caspi A; Tzukerman M; LeRoith D
    Breast Cancer Res; 2015 Jun; 17(1):78. PubMed ID: 26040280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
    Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
    Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.
    Drews-Elger K; Iorns E; Dias A; Miller P; Ward TM; Dean S; Clarke J; Campion-Flora A; Rodrigues DN; Reis-Filho JS; Rae JM; Thomas D; Berry D; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2014 Nov; 148(1):41-59. PubMed ID: 25270120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
    Xia TS; Wang GZ; Ding Q; Liu XA; Zhou WB; Zhang YF; Zha XM; Du Q; Ni XJ; Wang J; Miao SY; Wang S
    Breast Cancer Res Treat; 2012 Apr; 132(2):471-86. PubMed ID: 21638054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
    Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
    Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched.
    Balk-Møller E; Kim J; Hopkinson B; Timmermans-Wielenga V; Petersen OW; Villadsen R
    Am J Pathol; 2014 Apr; 184(4):1198-208. PubMed ID: 24655379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
    Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
    Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.
    Vantyghem SA; Wilson SM; Postenka CO; Al-Katib W; Tuck AB; Chambers AF
    Cancer Res; 2005 Apr; 65(8):3396-403. PubMed ID: 15833874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
    Ethier SP; Mahacek ML; Gullick WJ; Frank TS; Weber BL
    Cancer Res; 1993 Feb; 53(3):627-35. PubMed ID: 8425198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
    Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
    Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for luminal epithelial like ER positive subtype of human breast cancer.
    Kumar MJ; Ponvijay KS; Nandhini R; Nagarajan RS; Jose J; Srinivas G; Nagarajan P; Venkatesan R; Kumar K; Singh S
    BMC Cancer; 2007 Sep; 7():180. PubMed ID: 17880731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
    Salvador MA; Wicinski J; Cabaud O; Toiron Y; Finetti P; Josselin E; Lelièvre H; Kraus-Berthier L; Depil S; Bertucci F; Collette Y; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Clin Cancer Res; 2013 Dec; 19(23):6520-31. PubMed ID: 24141629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.